Pascal Leandri

Pascal Leandri, listed as board member, appears in our data through filings on Neolife shares, published by AMF. We count 34 filings; the first trade dates from 10 July 2023 and the latest from 28 May 2025.

In open-market terms, that means 31 purchases worth €261k on one side and 3 sales worth €654k on the other. The net balance comes to €392k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show no purchases and 1 sale.

The median purchase comes to €6,620. On 12 out of 31 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 31 purchases show a median change of +2.8%, with the price up in 52% of them. They describe history only and say nothing certain about the share price ahead.

On 2 June 2025 came the latest disclosure, an open-market sale for €628k in Neolife. The last insider purchase was made public on 23 October 2024, 724 days ago. The median gap between a trade and its publication by AMF is 5 days. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from AMF. Past trades are no guide to future returns.